Stephen MacMahon AO's Publications

About Stephen MacMahon AO's Publications

Founding Director, The George Institute for Global Health
  • Professor of Cardiovascular Medicine, Faculty of Medicine, UNSW Sydney
  • Chair of Global Health, Faculty of Medicine, Imperial College of London

  • Pharmacological blood-pressure lowering for the prevention of cardiovascular disease and death across the full spectrum of chronic kidney disease severity: an individual-participant data meta-analysis

    The Lancet Date published:

  • Blood Pressure Parameters and Risk of Cognitive Decline and Dementia in Type 2 Diabetes: Results From the ADVANCE Trial

    Journal of the American Heart Association Date published:

  • Assessment of adverse effects attributed to statin therapy in product labels: a meta-analysis of double-blind randomised controlled trials

    The Lancet Date published:

  • Blood pressure lowering in isolated diastolic hypertension and cardiovascular risk: an individual patient data meta-analysis

    European Heart Journal Date published:

  • Update on the Triple therapy prevention of Recurrent Intracerebral Disease EveNts Trial (TRIDENT)

    Date published:

  • Effect of randomised blood pressure lowering treatment and intensive glucose control on dementia and cognitive decline according to baseline cognitive function and other subpopulations of individuals with type 2 diabetes: Results from the ADVANCE trial

    Cerebral Circulation - Cognition and Behavior Date published:

  • Lifetime effects and cost-effectiveness of statin therapy for older people in the United Kingdom: a modelling study

    Heart Date published:

  • Effects of statin therapy on diagnoses of new-onset diabetes and worsening glycaemia in large-scale randomised blinded statin trials: an individual participant data meta-analysis

    The Lancet Diabetes & Endocrinology Date published:

  • Long-term cardiovascular risks and the impact of statin treatment on socioeconomic inequalities: a microsimulation model

    British Journal of General Practice Date published:

  • The Effects of a Perindopril-Based Regimen in Relation to Statin Use on the Outcomes of Patients with Vascular Disease: a Combined Analysis of the ADVANCE, EUROPA, and PROGRESS Trials

    Cardiovascular Drugs and Therapy Date published:

  • Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysis

    The Lancet Diabetes & Endocrinology Date published:

  • Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials

    The Lancet Date published:

  • Polypills for the prevention of cardiovascular disease: a framework for wider use

    Nature Medicine Date published:

  • Triple Therapy Prevention of Recurrent Intracerebral Disease Events Trial: Rationale, design and progress

    International Journal of Stroke Date published:

  • Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis

    The Lancet Date published:

  • The Impact of Frailty on the Effectiveness and Safety of Intensive Glucose Control and Blood Pressure-Lowering Therapy for People With Type 2 Diabetes: Results From the ADVANCE Trial

    Diabetes Care Date published: